Project cooperationUpdated on 21 January 2026
Clinical collaboration for thyroid cancer and thyroid disease biospecimen collection
Associate Professor of Surgery, University of Cagliari at University of Cagliari (UNICA)
Cagliari, Italy
About
Our clinical unit is available to collaborate within a Horizon project by providing access to surgical thyroid specimens and associated biological materials from patients undergoing surgery for thyroid cancer and other thyroid pathologies. We routinely perform around 400 thyroidectomies annually, ensuring a stable recruitment base and consistent availability of samples across a broad spectrum of thyroid conditions.
Within a project framework, we can:
-
Collect surgical thyroid tissue specimens generated during standard-of-care procedures (e.g., tumor and non-tumor tissue, when applicable).
-
Collect and provide additional biological samples as defined by the protocol (e.g., blood-derived samples or other biospecimens, depending on study needs and feasibility).
-
Process, store, and prepare samples for transfer, and ship biospecimens to project partners, in accordance with agreed SOPs and applicable ethical/legal requirements.
-
Support clinical annotation of samples (e.g., basic demographics, diagnosis, surgical details, pathology results, outcomes), subject to approvals and data governance.
This cooperation is intended for partners seeking clinically sourced biospecimens to enable translational research, biomarker discovery/validation, molecular profiling, or the development of diagnostic/prognostic tools in thyroid oncology and thyroid disease. Sample types, handling requirements, timelines, and data fields can be aligned to the consortium protocol.
Topic
- DESTINATION 4: HORIZON-HLTH-2026-01-CARE-01: Public procurement of innovative solutions for improving citizens' access to healthcare through integrated or personalised approaches
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
- DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
Type
- Partner seeks Consortium/Coordinator
Organisation
Similar opportunities
Project cooperation
NAM: organoids and OoC for drug discovery, and precision medicine applications
- Partner seeks Consortium/Coordinator
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
Una Riekstina
full professor at Department of Pharmaceutical Sciences, University of Latvia
Riga, Latvia
Project cooperation
Study the impact of climate change in the development and progression of Parkinson´s disease
- Partner seeks Consortium/Coordinator
- DESTINATION 2: HORIZON-HLTH-2026-01-ENVHLTH-01: Towards a better understanding and anticipation of the impacts of climate change on health
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
Laura Gómez Cuadrado
Head of Biomedicine and Cellular Toxicology at University of Burgos
Burgos, Spain
Project cooperation
Clinical Laboratory for Respiratory Pathogen Diagnostics and Validation
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
- DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
Vel Murugan
Professor at AZ Board of Regents on behalf of Arizona State University
Tempe, United States